Literature DB >> 20091823

Varenicline L-tartrate crystal forms: characterization through crystallography, spectroscopy, and thermodynamics.

Brendan J Murphy1, Jun Huang, Melissa J Casteel, Ana Cobani, Joseph F Krzyzaniak.   

Abstract

This research utilized crystallographic, spectroscopic, and thermal analysis data to assess the thermodynamic stability relationship between the three known crystal forms of Varenicline L-tartrate. Of the two anhydrous forms (Forms A and B), Form B was determined to be the stable form at 0 K based on its calculated true density, hydrogen bonding in the crystal lattice, and application of the IR rule. Form A has a higher melting point and higher solubility at room temperature as compared to Form B, indicating that these forms are enantiotropically related. Application of the eutectic-melting method enabled accurate determination of the transition temperature (63 degrees C), with Form B as the stable anhydrous form at room temperature. The stability relationships between the anhydrous polymorphs and the monohydrate (Form C) were assessed through exposure of the anhydrous forms to a range of water vapor pressures at room temperature. A phase boundary was identified, with the monohydrate being the thermodynamically stable form above critical water activity values of 0.85 and 0.94 for Forms A and B, respectively. These results provide a better understanding of the form stability as it relates to normal manufacturing and storage conditions for the active pharmaceutical ingredient and drug product.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091823     DOI: 10.1002/jps.22041

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers.

Authors:  Seong Shin Kwak; Eun Seok Lee; Ho Yub Yoon; Chang Hyun Kim; Yoon Tae Goo; Myung Joo Kang; Sangkil Lee; Bong Sang Lee; Hong Ryeol Jeon; Chang Hyun Oh; Young Wook Choi
Journal:  Drug Des Devel Ther       Date:  2018-10-09       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.